Case Type: Mergers & Acquisitions

We are investigating NRC Group Holdings Corp. (NRCG) related to its sale to US Ecology, Inc. Under the terms of the agreement, each share of NRC common stock will be converted into the right to receive 0.196 shares of US Ecology Parent, Inc. (wholly-owned subsidiary of US Ecology) common stock.

We are investigating PCM, Inc. (PCMI) regarding its acquisition by Insight Enterprises, Inc. Under the terms of the agreement, each share of PCM common stock will be converted into the right to receive $35.00 in cash per share.

We are investigating Caesars Entertainment Corporation (CZR) related to its merger with Eldorado Resorts, Inc. Under the terms of the proposed transaction, each share of Caesars common stock will be entitled to receive: (i) $8.40 per share in cash; and (ii) 0.0899 shares of Eldorado common stock, for each share of Caesars common stock owned.

We are investigating Rudolph Technologies, Inc. (RTEC) regarding its sale to Nanometrics Incorporated. Under the terms of the agreement, each share of Rudolph common stock will be converted into the right to receive 0.8042 shares of Nano common stock.

We are investigating LegacyTexas Financial Group, Inc. (LTXB) related to its merger agreement with Prosperity Bancshares, Inc. Under the terms of the agreement, each share of Legacy common stock will be converted into the right to receive: (i) 0.5280 shares of Prosperity common stock; and (ii) $6.28 in cash.

C&J Energy Services, Inc. (CJ) regarding its sale to Keane Group, Inc. Under the proposed transaction, each share of C&J common stock will be converted into the right to receive 1.6149 shares of Keane common stock.

We are investigating BioScrip, Inc. (BIOS) related to its merger agreement with HC Group Holdings II, Inc. (“Omega”), and HC Group Holdings I, LLC (“Omega Parent”). Under the terms of the agreement, each share of Omega’s common stock will be converted into the right of Omega Parent to receive 542,261,567 shares of BioScrip’s common stock.

We are investigating Sotheby’s (BID) regarding its sale to BidFair USA LLC. Under the terms of the agreement, Sotheby’s shareholders will receive $57.00 in cash for each share of Sotheby’s common stock they own.

We are investigating Array BioPharma Inc. (ARRY) regarding its sale to Pfizer Inc. Under the terms of the proposed agreement, each share of Array common stock will be converted into the right to receive $48.00 per share.

We are investigating Medidata Solutions, Inc. (MDSO) regarding its acquisition by Dassault Systèmes Americas Corp. Under the terms of the proposed transaction, each share of Medidata common stock is entitled to receive $92.25 in cash per share.